Caxton
Princeton, NJfiles as CAXTON CORP
$2m in 10 US stocks at the end of 30 June 2026. The top 10 are 100.0% of the money. It changed about 81.5% of the portfolio this quarter.
Value
$2m
Stocks
10
Top 10 share
100.0%
Turnover
81.5%
What changed this quarter
New
Bought for the first time this quarter.
- Space Exploration TechnologiesSPCX24.0% of the fund
- AlphabetGOOGL13.3% of the fund
- Vanguard Index FDSVOO12.6% of the fund
- BlackstoneBX10.2% of the fund
Added
Bought more of a stock they already held.
- Berkshire HathawayBRK-B20.3% of the fund+4%
- Lexeo TherapeuticsLXEO4.3% of the fund+22%
Cut
Sold some of their stake.
- Kyverna TherapeuticsKYTX5.9% of the fund-34%
Sold out
Sold their entire stake.
- Spdr Gold TRGLD-100%
Holdings
- Space Exploration TechnologiesSPCX
- Share
- 24.0%
- Value
- $445,346
- Shares
- 2,606
New
- Vanguard Index FDSVOO
- Share
- 12.6%
- Value
- $233,094
- Shares
- 339
New
| Company | Share of fund | Value | Shares | Change |
|---|---|---|---|---|
| Space Exploration TechnologiesSPCX | 24.0% | $445,346 | 2,606 | New |
| Berkshire HathawayBRK-B | 20.3% | $377,128 | 754 | +4% |
| AlphabetGOOGL | 13.3% | $246,906 | 691 | New |
| Vanguard Index FDSVOO | 12.6% | $233,094 | 339 | New |
| BlackstoneBX | 10.2% | $188,218 | 1,597 | New |
| Kyverna TherapeuticsKYTX | 5.9% | $110,009 | 12,347 | -34% |
| Lexeo TherapeuticsLXEO | 4.3% | $78,959 | 16,962 | +22% |
| X4 PharmaceuticalsXFOR | 3.9% | $72,650 | 15,557 | Held |
| Inhibikase TherapeuticsIKT | 3.1% | $57,759 | 28,453 | Held |
| ALX Oncology HoldingsALXO | 2.3% | $43,358 | 20,946 | Held |
Over time and by industry
Value over time
Jun '25
Dec '25
Jun '26
Value is down 81.2% since 30 June 2025.
Where the money is
Financial services30.5%
Technology24.0%
Health care19.6%
Media & telecom13.3%
Other12.6%
From the fund's 13F filings. They list US stocks and options only, 45 days after each quarter, and leave out cash, bonds, shorts and foreign shares.